Work

Regorafenib promotes antitumor progression in melanoma by reducing RRM2

Year: 2024

Type: article

Abstract: . In conclusion, our finding demonstrated that regorafenib promotes antitumor progression in melanoma by reducing RRM2.

Source: iScience

DOI: 10.1016/j.isci.2024.110993

Authors: Xiuyun Xuan, Yanqiu Li, Changzheng Huang, Yong Zhang

Institutions: Tongji Hospital, Huazhong University of Science and Technology, Jianghan University, Wuhan Union Hospital

Language: English

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,150

Funder: National Natural Science Foundation of China

Award: G8959750521

OpenAlex ID: W4402636740

FWCI: 0.462

Cites: 35

Cited by: 4

Related to: 10